UChicago endowment to invest in startups with roots on campus

The University of Chicago is designating $25 million from its endowment to invest alongside established venture funds in startups led by faculty, students, staff and alumni, expanding a commitment to grow entrepreneurship and research commercialization on campus. The Office of Investments, which manages the University’s $7.1 billion endowment, will oversee the UChicago Startup Investment Program as part of […]

New Businesses and Student Entrepreneurs through Startup Funding and University Support 

In today’s dynamic business landscape, launching a new enterprise demands dedication, ingenuity, and substantial resources. Among the critical determinants of a startup’s triumph, securing adequate funding stands out as paramount. Recognizing the pivotal role universities play in nurturing budding entrepreneurs, institutions are taking proactive steps to provide scholarships, startup funding, and a plethora of resources, magnifying […]

MTRAC awards $1M for mobility, transportation research

The Michigan Translational Research and Commercialization Advanced Transportation Innovation Hub at the University of Michigan recently awarded nearly $1 million to support eight multidisciplinary research projects with high commercial potential. U-M researchers from the Ann Arbor and Dearborn campuses, along with faculty from Western Michigan University, will receive a one-year grant from MTRAC to advance […]

How mentors help startups grow – and avoid costly mistakes

When Eric Reich was starting higher education software company Campus Labs in 2001, there weren’t a lot of ways to learn and process how to grow a startup. It made the mentors he had at the time that much more valuable. He leaned on local executives, such as Jordan Levy and Ron Schreiber, to help […]

An innovative path out of biotech’s “valley of death” – STAT

So many promising medical innovations never reach their full potential as therapies or cures, languishing instead in a metaphoric place many of us in biotech know as “the Valley of Death.” This valley represents the gap between when a scientist makes a discovery and when that work has reached the point when a pharmaceutical company […]

VIPC Awards Commonwealth Commercialization Fund Grant to ​​UVA for New Vaccine Platform for Infectious Diseases

RICHMOND, VIRGINIA, UNITED STATES, August 8, 2023/EINPresswire.com/ — The Virginia Innovation Partnership Corporation (VIPC) today announced that the University of Virginia (UVA) has been awarded a Commonwealth Commercialization Fund (CCF) grant for $75,000 in support of a commercialization project being conducted by Dr. Steven Zeichner. VIPC’s CCF programs have distributed more than $51 million to Virginia-based startups, entrepreneurs and […]

Kyoto University’s VC fund to invest $140m in AI and biotech – Nikkei Asia

Kyoto University-affiliated venture capital firm Miyako Capital has established a fund expected to raise roughly 20 billion yen ($141 million) to back startups involved in deep-tech biology and artificial intelligence. The fund will be one of the biggest vehicles of its kind in Japan, injecting between 500 million yen and 1 billion yen into each startup. Half the funds will go […]

5 lessons for academic founders swapping the lab bench for the boardroom | Sifted

Acareer in science no longer just means lab work, research papers and publishing in journals. More and more, scientific talent is entering tech by commercialising research and launching companies in everything from AI and quantum to drug discovery and carbon capture. But that brings with it its own challenges. Scientifically minded academics are usually more technical and […]

FACIT and T-CAIREM at the University of Toronto partner to commercialize medical AI

TORONTO, Aug. 2, 2023 /PRNewswire/ – Together with the University of Toronto’s Temerty Centre for Artificial Intelligence Research and Education in Medicine (T-CAIREM), FACIT announced a new partnership to commercialize artificial intelligence (AI) innovations. The partners intend to harness both T-CAIREM’s innovative translational research in AI and FACIT’s unique commercialization-venture model to build the next generation of Ontario biotechnology companies.  The joint […]